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Several variants of equine Cushing’s disease have been described
(1), with pituitary pars intermedia dysfunction (PPID) (2) being
the most widely recognised. Cushing’s disease is often character-
ised by hypertrophy and hyperplasia of the pituitary pars inter-
media, and is thought to result from a reduction in dopamine
synthesis or the degeneration of the periventricular hypophyseal
dopaminergic neurones (3). The clinical signs include hirsutism,
polydipsia, polyuria, increased protein catabolism (decreased mus-
cle mass), glucose intolerance and insulin refractoriness, suppres-
sion of the immune system and general lethargy (1). The disease
is progressive and occurs mainly in aged horses and ponies.
Many afﬂicted animals develop laminitis, a systemic disease (4,
5) with a seasonal onset, being most often observed in the
autumn.
Currently, the aetiology, pathogenesis and treatment of PPID
and Cushing’s syndrome are a matter of intense debate and
there is no reliable prophylaxis, or remedy, for the disease (2).
Treatments are generally given to ameliorate the clinical signs
and may include dopamine agonists, serotonin (5-hydroxytrypta-
mine⁄5-HT) antagonists (6, 7) and⁄or nonsteroidal anti-inﬂamma-
tory drugs and blood vessel dilators where laminitis has
developed (4). The administration of dopamine and its agonists
was reported to decrease plasma concentrations of pro-opiomela-
nocortin (POMC)-derived peptides (8). It has also been demon-
strated that vasoactive amines with molecular structures similar
to those of serotonin cause digital vasoconstriction and release
serotonin from equine platelets in vitro (9), and that 5-HT2
receptors mediate the effects of stress on the activity of
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Equine pituitary pars intermedia dysfunction (PPID) is a common and serious condition that gives rise
to Cushing’s disease. In the older horse, it results in hyperadrenocorticism and disrupted energy
metabolism, the severity of which varies with the time of year. To gain insight into the mechanism of
its pathogenesis, 24-h proﬁles for peripheral plasma melatonin, serotonin, dopamine and cortisol con-
centrations were determined at the winter and summer solstices, and the autumn and spring equi-
noxes in six horses diagnosed with Cushing’s disease and six matched controls. The nocturnal rises in
plasma melatonin concentrations, although different across seasons, were broadly of the same dura-
tion and similar amplitude in both groups of animals (P > 0.05). The plasma concentrations of cortisol
did not show seasonal variation and were different in diseased horses only in the summer when they
were higher across the entire 24-h period (P < 0.05). Serotonin concentrations were not signiﬁcantly
affected by time of year but tended to be lower in Cushingoid horses (P = 0.07). By contrast, dopa-
mine output showed seasonal variation and was signiﬁcantly lower in the Cushing’s group in the
summer and autumn (P < 0.05). The ﬁnding that the proﬁles of circulating melatonin are similar in
Cushingoid and control horses reveals that the inability to read time of year by animals suffering
from Cushing’s syndrome is an unlikely reason for the disease. In addition, the results provide evi-
dence that alterations in the dopaminergic and serotoninergic systems may participate in the patho-
genesis of PPID.
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From Molecular to Translational Neurobiologydopaminergic neurones in mice (10). Moreover, administration of
an inhibitor of 3-hydroxysteroid dehydrogenase, which reduces
cortisol production, appeared to be successful in decreasing the
incidence of laminitis in horses (11). Finally, in many seasonally
breeding mammalian species living in temperate zones, photope-
riod is the major environmental cue that controls annual physio-
logical cycles via both the effects of melatonin upon the
hypothalamic-pituitary axis (12) and dopamine in an inhibitory role
(13). Hence, all four neurohormones may be involved in the develop-
ment of PPID as a seasonally variable and known dopamine-
deﬁcient condition.
It has been observed that early diagnosis of Cushing’s disease
may be obscured by the overlap between phenotypic changes, as
well as by age and accompanying diseases (14). Because PPID is
most prevalent in older horses, it is important to consider the
possibility that concurrent phenotypic changes occur as a result
of gerontological alterations in neurohormonal concentrations.
These latter involve a progressive loss of central and peripheral
neurotransmitter and hormone sensitivity over time (15, 16), as a
result of degeneration of the pineal gland, and could result in
decreased serotonin and dopamine concentrations in peripheral
blood.
The present study aimed: (i) to test the hypothesis that the aged
horse cannot ‘read’ the time of the year because of deﬁciency in
melatonin production (and thus its circulating plasma concentra-
tion), resulting in an impaired 24-h proﬁle, and (ii) to examine the
link between the presence or absence of the clinical signs of Cush-
ing’s syndrome and differential peripheral plasma concentrations of
serotonin, dopamine and cortisol across the year in aged horses
and ponies.
Materials and methods
Animals
The chosen population represented a random selection of breeds or types of
horses and ponies from varied geographical locations throughout the UK.
The animals selected for the study remained at the same site throughout
the observation period; they were aged 21–36 years, had been retired from
work, and were kept at grass. During the December and March sampling
sessions, they were brought into stables from 16.00 h to 07.30 h. This regi-
men was started a minimum of 4 weeks in advance of the session as part
of their regular winter management. The study was conducted without mak-
ing any changes to the animals’ normal feeding and management regimen.
All experimental protocols were carried out in strict accordance with UK
Home Ofﬁce regulations.
Experimental strategy and design
Two groups were constructed from the population: a ‘diseased’ (or Cushingoid)
and a ‘control’ group. The former consisted of horses and ponies with a veteri-
nary history that strongly implied the presence of Cushing’s disease, or where
external examination conﬁrmed the same. The control group was selected
from the same population with each member matching an individual in the
disease group as closely as possible in breed⁄type, gender, weight and height.
Static hormonal and biochemical determinations from a blood plasma or
serum sample obtained via jugular venepuncture were performed to conﬁrm
the assignment. The predominance of the following values indicated correct
allocation to the Cushing’s group: adrenocorticotrophic hormone > 50 pg⁄ml,
cortisol > 155 nmol⁄l, glucose > 7.50 mmol⁄l, triglycerides > 0.76 mmol⁄l,
cholesterol > 2.84 mmol⁄l, magnesium < 0.71 mmol⁄l and alkaline phospha-
tase > 326 U⁄l (5, 17, 18). From the starting pool of animals, six matched
pairs with a good expectation of survival to the end of the study and negli-
gible anxiety during jugular venepuncture were selected.
Blood samples were collected at 27-h intervals over 4 · 10-day periods,
each scheduled to span consecutive solstices and equinoxes throughout a
year. Day 1 commenced at 13.00 h and was a control for day 9, also at
13.00 h. All sampling during hours of darkness was conducted using red
light to minimise any effects on the pineal gland. Different operators were
used to draw samples from different horses across both groups to reduce
bias. Because the horses and ponies were at grass, they were caught and
brought into catch-up areas in the hour preceding the sampling start time;
each individual was secured and given a minimum of 20 min in a calm
state before sampling commenced. The samples were then collected from
the jugular vein via needle and syringe, gently transferred to Vacutainer:
Becton, Dickson and Company, Franklin Lakes, NJ, USA spray-coated K2EDTA
plastic tubes (without using a vacuum, i.e. not through the cap) and kept
within insulated boxes at 2–8  C. They were promptly centrifuged at 1300 g
for 12 min within 2 h of collection, immediately processed and stored
short-term between )25 and )30  C. Platelet-poor plasma samples for
serotonin determinations were centrifuged at 4500 g for 10 min. Long-term
storage in the laboratory was at )75  C.
To be able to examine individual circadian proﬁles in accordance with the
UK Animal Welfare regulations, the experimental design included a consis-
tent time slot for each animal on each sampling day. For example, Horse 1
had a sample drawn at 13.00 h on day 1. This individual would then have a
sample drawn at 16.00 h on day 2. Similarly, Horse 2 had a sample drawn
at 13.06 h on day 1 and at 16.06 h on day 2. Thus, the time slots were
6 min apart and were maintained for each individual over the course of the
study. Using this design, the results from all horses on day 1 were desig-
nated as ‘time point 13.00 h’, from day 2 as 16.00 h, from day 3 as
19.00 h, and so on, until day 9 when blood collection at 13.00 h (control
for day 1) terminated the experiment. Because the natural rhythms of the
horses were being observed in the context of daylight-saving time (the UK
yearly shifts between GMT and BST and horses adapt to management and
feeding changes associated with this), all sampling times are as would be
expected in the UK (i.e. GMT for December and March, BST for June and
September).
EDTA plasma radioimmunoassays (RIA)
Commercial
125I RIA kits were obtained for quantitative determinations of
melatonin, serotonin and dopamine (Labor Diagnostika Nord GmbH & Co,
KG, Nordhorn, Germany). These kits were validated for use with equine
plasma via standard parallel and serial dilution techniques, and also by run-
ning test samples at the same concentrations within the same assay kit and
across different assay kits of the same product code. Analytical sensitivity,
as reported by the manufacturer, was 0.4 pg⁄ml (400 ll version), 10 ng⁄ml
and 6 pg per sample volume unit extracted (ml) for the melatonin, serotonin
and dopamine kits, respectively.
Endogenous melatonin was removed by adsorption to activated charcoal
and an ‘Equalising Reagent’ (i.e. melatonin-free biological liquid), in this case
equine plasma, was then used to equalise the assay matrix of standards and
untreated samples. All samples, including the standards, were digested by a
protease to reduce nonspeciﬁc binding. To prepare samples for serotonin
determination, an acylation reagent was used to convert the serotonin into
N-acylserotonin quantitatively. Dopamine was extracted using a cis-diol spe-
ciﬁc afﬁnity gel, acylated to N-acyldopamine and then converted enzymati-
cally during the detection procedure into N-acyl-3-methoxytyramine.
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hormone quantiﬁcation in the samples from the study (400 ll). Intra- and
inter-assay coefﬁcients of variation (CV) were in the range 4.2–19.7% and
9.4–22%, respectively, and the mean recovery was 100.2%. Mean linearity
was 84.9%. Testing of the dopamine kit was carried out to conﬁrm its reli-
ability in measuring the low content of dopamine in equine plasma. The
intra-assay CV was in the range 10.5–12.4% and the inter-assay CV was in
the range 10.1–17.8%. The analytical recovery of dopamine was estimated
at eight different concentrations by using the theoretically expected and the
actually measured values; the mean recovery was 92.3%. Linearity was
determined using seven different dilutions of a serum sample with serum
equalising reagent; this gave a mean linearity value of 98.9%.
Cortisol was quantiﬁed via an enzyme-linked immunosorbent assay using
commercial kits from DRG Instruments GmbH (Marburg, Germany) that were
validated for use with equine plasma in a manner similar to that for the
RIA kits. Intra- and inter-assay CVs were in the range 3.2–8.1% and 6.5–
7.7%, respectively. The mean recovery was 97.1% and mean linearity, 98.1%.
Prior to assay, the samples were thawed at room temperature (approxi-
mately 20  C), immediately centrifuged at 6  C and 3000 g for 5 min to
remove any particulates, and the supernates assayed without delay. The
assay kit protocols, timescales and quality control measures were strictly
adhered to. As far as possible, all samples from the same horse or pony
were analysed at the same time in the same kit for each sampling
period.
Statistical analysis
All analyses were carried out by QI Statistics Ltd (Reading, UK) using SAS
software (Statistical Analysis System, Cary, NC, USA). In the ﬁrst instance,
the control days (i.e. days 1 and 9) were compared using the difference in
adjusted mean scores between Time 1 (13.00 h on day 1) and Time 9
(13.00 h on day 9) for each condition (control or Cushingoid) group via a
t-test. Overall, there was no evidence for a signiﬁcant difference between
the average hormone concentrations on either of the two control days for
any of the seasonal sampling periods. Thus, it was assumed that the result
on each sequential day was reliable.
Data were shown to be normally distributed and were statistically
analysed in ﬁve stages. Stage 1: Due to the involvement of multiple
variables in this study, a multifactorial (three-way) split-plot ANOVA was
carried out initially to examine the effects of, and interaction between,
condition (normal versus Cushingoid), season and time of day for each
hormone; condition, season and the interaction between condition and
season were applied to the main plot, whereas time, and interaction
between time and condition and time and season were applied to the
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Fig. 1. Twenty-four-hour patterns of blood plasma concentration of melatonin in aged horses with Cushing’s disease (light line) and aged control animals
(dark line) at four times of the year. Values at each time point represent the mean  SEM. Sunset to sunrise is indicated by the solid bar above the graphs.
The 24-h sample collections began at 13.00 h, but for clarity results are plotted starting at 07.00 h.
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tonin were also analysed in this manner (the ratio directions were selected
to minimise the effect of zero or missing data in denominators). Stage 2:
The aforementioned original analysis of each hormone was followed by
individual split-plot (two-way) ANOVAs with repeated measurements over
time for each season; in this case, condition was applied to the main plot,
whereas time and the interaction between time and condition were
applied to the sub-plot. Stage 3: Due to the diurnal variations in magni-
tude of some hormones, analyses of the light and dark periods were then
carried out separately; the photophase and scotophase were deﬁned using
the sunrise and sunset times for the latitude and longitude of the site.
Stage 4: Finally pairwise comparisons of the differences in adjusted means
at each time point were conducted for each hormone in each season
using a t-test. Stage 5: In addition to the above analyses, the diurnal
rhythms in hormone concentrations and the hormonal ratios previously
speciﬁed were examined by cosinor analysis. The cosinor model was ﬁtted
using the PROC NLIN (nonlinear procedure) of SAS to take into account the
amplitude, the extent of the cyclic variation around the average value and
the acrophase. Subsequently, ANOVA was carried out on the shape parame-
ters using the PROC GLN (general linear model procedures) of SAS. All graph-
ical data are presented as adjusted means  SEM.
Results
The 24-h proﬁles of melatonin for control and Cushingoid horses in
each season are shown in Fig. 1. A highly signiﬁcant effect of time
of year (month) was observed in the total daily secretion of melato-
nin (P < 0.002); similarly, the 24-h proﬁle was affected by month
(P < 0.02). By contrast, no differences were detected between con-
trol and diseased horses for either the total melatonin output or its
24-h proﬁle in any month (ANOVA: P > 0.05). This was corroborated
by cosinor analysis, which showed no signiﬁcant differences
between the two groups of animals for either the acrophase or the
amplitude of the nocturnal peak (P > 0.05).
The 24-h peripheral plasma concentrations of serotonin are dis-
played in Fig. 2. The total secretion within a day was not inﬂuenced
by time of year. However, the 24-h proﬁles differed across seasons
(time · month interaction P < 0.02). Signiﬁcant daily changes were
detected in June (P < 0.05) and December (P < 0.01). A tendency
was also noted for the effect of condition (i.e. control versus
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Fig. 2. Twenty-four-hour patterns of blood plasma concentration of serotonin in aged horses with Cushing’s disease (light line) and aged control animals
(dark line) at four times of the year. Values at each time point represent the mean  SEM. Sunset to sunrise is indicated by the solid bar above the graphs.
The 24-h sample collections began at 13.00 h but, for clarity, the results are plotted starting at 07.00 h. Pairwise comparisons of means at speciﬁc time points
were performed and signiﬁcant differences are indicated by asterisks; *P < 0.05, **P < 0.01.
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itself (P = 0.06). Indeed, concentrations of serotonin were signiﬁ-
cantly lower at certain times during both the light and dark phases
of the 24-h light⁄dark cycle (P < 0.05) in Cushingoid animals dur-
ing summer (June) and winter (December).
The total amount of dopamine released within the 24-h period
was signiﬁcantly affected by season (P < 0.05) and markedly differ-
ent between control and Cushingoid horses (P < 0.001). As shown
in Fig. 3, diseased animals exhibited signiﬁcantly lower plasma con-
centrations at speciﬁc times of day in March, June and September.
There was a tendency for effect of condition on the overall 24-h
proﬁle to be inﬂuenced by season (time · condition · month inter-
action; P = 0.07), with signiﬁcant time · condition interactions
when the proﬁles were analysed separately for the dark and light
phases of the 24-h cycle (P < 0.05). Finally, cosinor modelling
detected a tendency (P = 0.08) for a phase shift in the dopamine
acrophase in diseased animals with a peak just over 3 h later than
in controls.
The multifactorial ANOVA showed that overall amounts of cortisol
secreted during a day and its 24-h proﬁles were not affected by
season or condition (P > 0.05 for both). Similarly, cosinor analysis
revealed no differences in either the acrophase or amplitude
(P > 0.05). Because it was felt that the lack of signiﬁcant differ-
ences was due, at least in part, to the interanimal variability, indi-
vidual ANOVAs for each season were carried out. They revealed that,
in June (Fig. 4), plasma hormone concentrations in Cushingoid
horses were signiﬁcantly higher at almost all time points
(P < 0.01).
A signiﬁcant effect of season was detected on the ratios of the
total daily secretions of serotonin : melatonin (P < 0.05) and dopa-
mine : melatonin (P < 0.01) and the 24-h proﬁles for both ratios
were signiﬁcantly affected by month (P < 0.001). Moreover, the
ratios of serotonin : melatonin and dopamine : melatonin total
secretions were different in Cushingoid and control horses
(P < 0.001 and P < 0.005, respectively), as were their proﬁles in dif-
ferent seasons (condition · season interaction P < 0.001 for both).
Values of the two ratios that differed signiﬁcantly between control
and diseased horses at different times of the day in the four seasons
of the year are summarised in Table 1. Cosinor modelling showed a
signiﬁcant change in the amplitude for the dopamine : melatonin
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Fig. 3. Twenty-four-hour patterns of blood plasma concentration of dopamine in aged horses with Cushing’s disease (light line) and aged control animals
(dark line) at four times of the year. Values at each time point represent the mean  SEM. Sunset to sunrise is indicated by the solid bar above the graphs.
The 24-h sample collections began at 13.00 h but, for clarity, the results are plotted starting at 07.00 h. Pairwise comparisons of means at speciﬁc time points
were performed and signiﬁcant differences are indicated by asterisks; *P < 0.05, **P < 0.01.
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(P = 0.059). In both cases, the Cushingoid horses had much lower
amplitude values than did the controls.
Discussion
The results of the present study can be summarised as follows:
(i) the 24-h patterns of plasma melatonin concentrations during
the four seasons of the year in Cushingoid animals were similar to
those in controls; (ii) plasma serotonin proﬁles were affected by
season, and serotonin concentrations tended to be lower in
Cushingoid horses in summer (June) and winter (December); (iii) the
total amount of dopamine released was dependent on season and
markedly lower in Cushingoid versus control horses; (iv) total
amounts of cortisol in plasma throughout the 24-h proﬁle were
signiﬁcantly higher in diseased horses only in June; and (v) large
changes, mostly reductions, were seen in the serotonin : melatonin
and dopamine : melatonin ratios in the diseased animals. Although
our investigation does not discriminate between the effects that
these circulating plasma neurohormones may have on the periph-
eral and⁄or central dopaminergic systems implicated in the patho-
genesis of Cushing’s disease, our results do provide evidence for
possible direct or indirect contributory effects from dopamine and
serotonin.
To the best of our knowledge, this is the ﬁrst systematic study
that has measured plasma concentrations of melatonin, serotonin,
dopamine and cortisol simultaneously across a 24-h period at four
seasons of the year in horses with Cushing’s disease and age-
matched controls. Our results, even for control animals, are difﬁcult
to compare with those in the literature because of the paucity of
relevant published information.
The 24-h melatonin output was affected by season of year,
reﬂecting the increased duration of the nocturnal peak during the
short days of autumn and winter. Nocturnal increases in melato-
nin, which were longer during longer nights, have been seen pre-
viously (19, 20) but no patterns were reported for the light
period. Diekman et al. (21) compared seasonal variations in the
concentration of melatonin in peripheral blood in light and dark,
but noted a nocturnal rise only in June. The mean (or median)
values for the plasma concentration of melatonin in all the above
studies were very similar to those in Fig. 1. Our results in horses
with Cushing’s disease showed that their melatonin rhythm
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Fig. 4. Twenty-four-hour patterns of blood plasma concentration of cortisol in aged horses with Cushing’s disease (light line) and aged control animals (dark
line) at four times of the year. Values at each time point represent the mean  SEM. Sunset to sunrise is indicated by the solid bar above the graphs. The 24-h
sample collections began at 13.00 h but, for clarity, the results are plotted starting at 07.00 h. Pairwise comparisons of means at speciﬁc time points were
performed and signiﬁcant differences are indicated by asterisks; *P < 0.05, **P < 0.01.
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it did in controls, which indicates that an inability of the animals
to ‘read’ the time of the year is unlikely to be the cause of the
disease. This important observation demonstrates that the transla-
tion of photoperiodic information is maintained in horses suffer-
ing from PPID and, therefore, does not support our original
working hypothesis.
In a previous study, peripheral plasma concentrations of seroto-
nin were measured in summer, autumn, winter and spring in clini-
cally normal ponies and those predisposed to laminitis, and
no signiﬁcant differences were observed (22). Although light⁄dark
differences were not investigated in the latter work, nyctohemeral
increases in serum serotonin in the healthy, athletic horse have
been reported (23). The present study shows that the concentration
of free serotonin is decreased at speciﬁc times of the year in horses
with Cushing’s disease. Although the reasons for this reduction
remain unknown, enhanced conversion of serotonin to melatonin
could account, at least in part, for the lowered circulating level. It
should be noted that the amount of serotonin detected in plasma
depends on the number of platelets present (24) and is much lower
in platelet-poor samples, such as determined in the present study
and the previous study by Bailey et al. (22).
Plasma dopamine concentrations were signiﬁcantly decreased at
speciﬁc times of the year in horses with Cushing’s disease. In a
previous study, an over 80% decline in the content of this neuro-
hormone (as well as of its metabolites) had been observed in the
equine pituitary pars intermedia of Cushingoid animals (25). Simi-
larly, McFarlane et al. (3, 26) reported that horses with PPID had
ﬁve-fold less tyrosine hydroxylase staining and increased levels of
3-nitrotyrosine, a marker for oxidative stress. This suggests that a
decreased central content of dopamine and reduced dopaminergic
tone may play a role in the pathogenesis of Cushing’s disease.
Whether or not the reduced level of circulating hormone observed
in the present study is a consequence of the decrease in the pitui-
tary pars intermedia cannot be resolved on the basis of the present
experiments. Notwithstanding, our observations are consistent with
previous ﬁndings that administration of dopamine agonists beneﬁts
the PPID horse (6, 7).
Equine plasma concentrations of cortisol were similar to those
found in previous studies (27–29) and did not demonstrate the circa-
dian rhythm described by some investigators (28). However, Irvine
and Alexander (28) showed that the circadian rhythm of cortisol can
easily be obliterated in normal horses, but not trained racehorses, by
minor perturbations in the environment. Moreover, it is possible that
increased age of the animal is also one of the obliterating factors.
Nevertheless, it was interesting to ﬁnd that the concentrations of this
hormone were increased in Cushingoid horses only during the sum-
mer, which corroborates the selective alteration of the hypothalamic-
pituitary-adrenal axis at this time of the year.
It is important to note that, in the present study, three fac-
tors may have obscured, or minimised, differences between the
Cushingoid and control horses: the relatively small number of
experimental animals, a large inter-animal variation (encountered
in most studies on large live, whole mammals) and the speciﬁc
Table 1. Neurohormone Concentration Ratios in Cushingoid and Control Horses Across all Seasons.
Date
Time
(h)
Ser : Mel
(ng⁄ml : pg⁄ml)
Dop : Mel
(pg⁄ml : pg⁄ml)
Control Cushingoid Control Cushingoid
March 10.00 27.5  6.69 4.61  9.72* 10.8  2.84 2.22  4.13*
13.00 16.6  2.81 9.50  3.00*
19.00 6.73  1.15 2.11  1.68**
22.00 6.18  1.42 1.30  1.68** 7.60  1.54 1.17  1.82***
01.00 7.71  1.42 0.80  1.68***
June 07.00 72.0  16.1 7.50  18.1*** 34.0  12.2 4.99  11.46*
13.00 50.6  12.6 17.8  13.6* 28.6  9.49 5.27  10.3***
19.00 37.8  12.2 5.03  10.3**
22.00 14.6  2.71 8.43  2.86* 2.85  2.03 8.03  1.96*
01.00 9.49  2.42 1.71  3.36*
04.00 14.8  2.71 2.31  2.86*** 5.38  2.03 0.84  1.96*
September 16.00 291  65.7 18.7  68.3*** 173  41.4 10.2  56.5**
22.00 9.53  1.84 2.66  1.99** 7.39  1.08 0.50  1.28****
01.00 8.01  2.12 1.51  1.99**
December 07.00 11.4  2.21 4.29  2.34** 12.3  2.28 1.73  2.70***
10.00 414  61.0 39.3  49.1**** 323  60.2 17.1  56.8****
22.00 10.6  2.21 2.45  2.34** 9.97  2.28 4.28  2.70*
01.00 15.3  1.98 1.77  2.34****
04.00 9.40  1.98 2.97  2.34**
Values are adjusted means  SEM for statistically signiﬁcant results. Mel, melatonin; Ser, serotonin; Dop, dopamine.
*P < 0.1, **P < 0.05, ***P < 0.01, ****P < 0.001. All other ratios were nonsigniﬁcant and are not shown.
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regulations which did not allow blood sampling of individuals
every 3 h. To address one of these issues, we evaluated the
serotonin : melatonin and dopamine : melatonin ratios using the
same statistical methods. It is well known that ratios are less
sensitive to inter-subject variations and that a number of physio-
logical processes depend on a ratio of two effectors and not
their absolute levels. Analyses of these additional results provide
strong support for our arguments.
In conclusion, comparisons of circadian rhythms for melatonin,
serotonin, dopamine and cortisol in four seasons of the year in
horses with Cushing’s disease and their age-matched controls
implicate both dopamine and serotonin in the pathogenesis of the
disease. The similar durations of the nocturnal melatonin peaks in
both groups of animals suggests that photoperiodic information in
Cushingoid horses can be processed normally and, therefore, that
impaired melatonin output is unlikely to be the reason for the circ-
annual manifestation of the disease.
Acknowledgements
This study was supported by the Department of Trade and Industry, UK, the
Laminitis Trust and the Horse Trust. The editorial assistance and advice of
Professors I. Silver and M. Erecinska is highly appreciated, as are the contri-
butions to the experimental work by Mark Belshaw, Mr and Mrs J. Haritou,
Mr J. Mason and family, Charlotte Pardon, Samantha Donald, Will Sander-
son, Martin Whiting, Sarah Styles, Emma Cleaver, Michele Zylstra, Aine Has-
sett and Kev Ireton. Quality control, reﬁnement and additional testing of the
assay kits was carried out by Dipl.-Ing. Biotechnol. Andre ´ Welp, Nadine Kru ¨g
and Dr Bernhard Manz; additional technical RIA queries were resolved with
Esther Booltink and Matthias Kuper (Labor Diagnostika Nord GmbH & Co
KG, 48531 Nordhorn, Germany). Statistical analyses were kindly performed
by Anne Hasted and Ian Wakeling (QI Statistics Ltd, Reading, UK) and the
cortisol assays by Zuo Yen Lee.
Received: 1 August 2007,
revised 30 April 2008,
accepted 2 May 2008
References
1 Johnson PJ. The equine metabolic syndrome – peripheral Cushing’s syn-
drome. Vet Clin North Am Equine Pract 2002; 18: 271–293.
2 Schott HC. Pituitary pars intermedia dysfunction: equine Cushing’s dis-
ease. Vet Clin North Am Equine Pract 2002; 18: 237–270.
3 McFarlane D, Donaldson MT, Saleh TM, Cribb AE. The Role of Dopaminer-
gic Neurodegeneration in Equine Pituitary Pars Intermedia Dysfunction
(Equine Cushing’s Disease). New Orleans, LA: Forty-ninth Annual
Convention of the American Assocication of Equine Practitioners. http://
www.ivis.org/proceedings/AAEP/2003/macfarlane/ivis.pdf, 2003.
4 Hood DM. Laminitis as a systemic disease. Vet Clin North Am Equine
Pract 1999; 15: 481–494.
5 Bailey SR, Marr CM, Elliott J. Current research and theories on the
pathogenesis of acute laminitis in the horse. Vet J 2004; 167: 129–
142.
6 Donaldson MT, LaMonte BH, Morresey P, Smith GJB. Treatment with per-
golide or cyproheptadine of pituitary pars intermedia dysfunction
(equine Cushing’s disease). J Vet Intern Med 2002; 16: 742–746.
7 Perkins GA, Lamb S, Erb HN, Schanbacher B, Nydam DV, Divers TJ.
Plasma adrenocorticotropin (ACTH) concentrations and clinical response
in horses treated for equine Cushing’s disease wih cyproheptadine or
pergolide. Equine Vet J 2002; 34: 679–685.
8 Orth DN, Holscher MA, Wilson MG, Nicholson WE, Plue RE, Mount CD.
Equine Cushing’s disease: plasma immunoreactive proopiolipomelanocor-
tin peptide and cortisol levels basally and in response to diagnostic
tests. Endocrinology 1982; 110: 1430–1441.
9 Elliott J, Berhane Y, Bailey SR. Effects of monoamines formed in the
cecum of horses on equine digital blood vessels and platelets. Am J Vet
Res 2003; 64: 1124–1131.
10 Goudreau JL, Manzanares J, Lookingland KJ, Moore KE. 5HT2 receptors
mediate the effects of stress on the activity of periventricular hypophy-
seal dopaminergic neurons and the secretion of alpha-melanocyte-
stimulating hormone. J Pharmacol Exp Ther 1993; 265: 303–307.
11 McGowan CM, Neiger R. Efﬁcacy of trilostane for the treatment of
equine Cushing’s syndrome. Equine Vet J 2003; 35: 414–418.
12 Lincoln GA, Almeida OF, Klandorf H, Cunningham RA. Hourly ﬂuctuations
in the blood levels of melatonin, prolactin, lutenizing hormone, follicle
stimulating hormone, testosterone, tri-iodothyronine, thyroxine and cor-
tisol in rams under artiﬁcial photoperiods, and the effects of cranial
sympathectomy. J Endocrinol 1982; 92: 237–250.
13 Tortonese DJ. Interaction between hypothalamic dopaminergic and opio-
idergic systems in the photoperiodic regulation of pulsatile luteinizing
hormone secretion in sheep. Endocrinology 1999; 140: 750–757.
14 McFarlane D, Beech J, Cribb A. Alpha-melanocyte stimulating hormone
release in response to thyrotropin-releasing hormone in healthy horses,
horses with pituitary pars intermedia dysfunction and equine pars
intermedia explants. Domest Anim Endocrinol 2006; 30: 276–288.
15 Dilman VM, Revskoy SY, Golubev AD. Neuroendocrine-ontogenetic mech-
anism of aging: toward an integrated theory of aging. Int Rev Neurobiol
1986; 28: 89–156.
16 Dilman VM, Yound JK. Development, Aging and Disease – A New Ratio-
nale for an Intervention Strategy. Chur: Harwood Academic Publishers,
1994.
17 Couetil L, Paradis MR, Knoll J. Plasma adrenocorticotropin concentration
in healthy horses and in horses with clinical signs of hyperadrenocortic-
ism. J Vet Intern Med 1996; 10: 1–6.
18 Knottenbelt DC. Saunders Equine Formulary. Liverpool: Saunders Elsevier,
2006.
19 Guerin MV, Deed JR, Kennaway DJ, Matthews CD. Plasma melatonin in
the horse: measurements in natural photoperiod and in acutely extended
darkness throughout the year. J Pineal Res 1995; 19: 7–15.
20 Guillaume D, Rio N, Toutain PL. Kinetic studies and production rate of
melatonin in pony mares. Am J Physiol 1995; 268: R1236–R1241.
21 Diekman MA, Braun W, Peter D, Cook D. Seasonal serum concetrations
of melatonin in cycling and non-cycling mares. J Anim Sci 2002; 80:
2949–2952.
22 Bailey SR, Katz LM, Berhane Y, Samuels T, De Brauvere N, Marr CM, Elli-
ott J. Seasonal changes in plasma concentrations of cecum-derived
amines in clinically normal ponies and ponies predisposed to laminitis.
Am J Vet Res 2003; 64: 1132–1138.
23 Piccione G, Assenza A, Fazio F, Percipalle M, Caola G. Central fatigue
and nycthemeral change of serum tryptophan and serotonin in the ath-
letic horse. J Circadian Rhythms 2005; 3: 6–9.
24 Bailey SR, Elliott J. Plasma 5-hydroxytryptamine constricts equine digital
blood vessels in vitro: implications for pathogenesis of acute laminitis.
Equine Vet J 1998; 30: 124–130.
25 Millington WR, Dybdal NO, Dawson R, Manzini C, Mueller GP. Equine
Cushing’s disease: differential regulation of beta-endorphin processing
in tumors of the intermediate pituitary. Endocrinology 1988; 123:
1598–1604.
Melatonin, serotonin, dopamine, cortisol in equine Cushing’s disease 995
ª 2008 Pegasus Equine Diagnostics Ltd. Journal Compilation ª 2008 Blackwell Publishing Ltd, Journal of Neuroendocrinology, 20, 988–99626 McFarlane D, Dybdal NO, Donaldson MT, Miller L, Cribb AE. Nitration and
increased alpha-synuclein expression associated with dopaminergic neu-
rodegeneration in equine pituitary pars intermedia dysfunction. J Neuro-
endocrinol 2005; 17: 73–80.
27 Johnson AL, Malinowski K. Daily rhythm of cortisol, and evidence for a
photo-inducible phase for prolactin secretion in nonpregnant mares
housed under non-interrupted and skeleton photoperiods. J Anim Sci
1986; 63: 169–175.
28 Irvine CHG, Alexander SL. Factors affecting the circadian rhythm in
plasma cortisol concentrations in the horse. Domest Anim Endocrinol
1994; 11: 227–238.
29 Black A, Schoknecht PA, Ralston SL, Shapses SA. Diurnal variation and
age differences in the biochemical markers of bone turnover in horses.
J Anim Sci 1999; 77: 75–83.
996 S. J. A. Haritou et al.
ª 2008 Pegasus Equine Diagnostics Ltd. Journal Compilation ª 2008 Blackwell Publishing Ltd, Journal of Neuroendocrinology, 20, 988–996